Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature

Clin Adv Hematol Oncol. 2006 Sep;4(9):678-82.

Authors

Lionel Adès¹, Pierre Fenaux

Affiliation

¹ Service d'Hématologie clinique at the Assistance Publique-Hopitaux de Paris (AP-HP), Hopital Avicenne, 93009 Bobigny, France.

PMID: 17099625

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cytarabine / adverse effects
Cytarabine / therapeutic use*
Humans
Leukemia, Promyelocytic, Acute / drug therapy*
Randomized Controlled Trials as Topic
Recurrence
Risk Factors
Treatment Outcome

Substances

Cytarabine